Compendium of Cancer Genome Aberrations

Changes

HAEM5:Hepatosplenic T-cell lymphoma (view source)

Revision as of 13:47, 10 February 2025

1,305 bytes added ,  10 February
no edit summary
Line 84: Line 84:  
|Negative||CD5, CD4, CD8<ref name=":1" />
 
|Negative||CD5, CD4, CD8<ref name=":1" />
 
|}
 
|}
−
==Chromosomal Rearrangements (Gene Fusions)==
+
==WHO Essential and Desirable Genetic Diagnostic Criteria==
 +
<span style="color:#0070C0">(''Instructions: The table will have the diagnostic criteria from the WHO book <u>autocompleted</u>; remove any <u>non</u>-genetics related criteria. If applicable, add text about other classification'' ''systems that define this entity and specify how the genetics-related criteria differ.'')</span>
 +
{| class="wikitable"
 +
|+
 +
|WHO Essential Criteria (Genetics)*
 +
|
 +
|-
 +
|WHO Desirable Criteria (Genetics)*
 +
|
 +
|-
 +
|Other Classification
 +
|
 +
|}
 +
<nowiki>*</nowiki>Note: These are only the genetic/genomic criteria. Additional diagnostic criteria can be found in the [https://tumourclassification.iarc.who.int/home <u>WHO Classification of Tumours</u>].
 +
==Related Terminology==
 +
<span style="color:#0070C0">(''Instructions: The table will have the related terminology from the WHO <u>autocompleted</u>.)''</span>
 +
{| class="wikitable"
 +
|+
 +
|Acceptable
 +
|
 +
|-
 +
|Not Recommended
 +
|
 +
|}
 +
 
 +
==Gene Rearrangements==
    
*No known chromosomal rearrangements at this time
 
*No known chromosomal rearrangements at this time
   −
==Individual Region Genomic Gain / Loss / LOH==
+
==Individual Region Genomic Gain/Loss/LOH==
    
{| class="wikitable sortable"
 
{| class="wikitable sortable"
Line 144: Line 169:  
|Seen in 10-15% of cases<ref name=":1" />
 
|Seen in 10-15% of cases<ref name=":1" />
 
|}<br />
 
|}<br />
−
==Characteristic Chromosomal Patterns==
+
==Characteristic Chromosomal or Other Global Mutational Patterns==
    
*7q aberrations and trisomy 8 are considered specific for HSTL, but not sensitive<ref name=":2" />
 
*7q aberrations and trisomy 8 are considered specific for HSTL, but not sensitive<ref name=":2" />
Line 182: Line 207:  
|occur in a significant minority of HSTL cases<ref name=":4" />
 
|occur in a significant minority of HSTL cases<ref name=":4" />
 
|}<br />
 
|}<br />
−
==Gene Mutations (SNV / INDEL)==
+
==Gene Mutations (SNV/INDEL)==
    
{| class="wikitable sortable"
 
{| class="wikitable sortable"
Line 394: Line 419:     
==References==
 
==References==
−
(use the "Cite" icon at the top of the page) <span style="color:#0070C0">(''Instructions: Add each reference into the text above by clicking on where you want to insert the reference, selecting the “Cite” icon at the top of the page, and using the “Automatic” tab option to search such as by PMID to select the reference to insert. The reference list in this section will be automatically generated and sorted.''</span> <span style="color:#0070C0">''If a PMID is not available, such as for a book, please use the “Cite” icon, select “Manual” and then “Basic Form”, and include the entire reference''</span><span style="color:#0070C0">''.''</span><span style="color:#0070C0">) </span> <references />
+
(use the "Cite" icon at the top of the page) <span style="color:#0070C0">(''Instructions: Add each reference into the text above by clicking where you want to insert the reference, selecting the “Cite” icon at the top of the wiki page, and using the “Automatic” tab option to search by PMID to select the reference to insert. If a PMID is not available, such as for a book, please use the “Cite” icon, select “Manual” and then “Basic Form”, and include the entire reference. To insert the same reference again later in the page, select the “Cite” icon and “Re-use” to find the reference; DO NOT insert the same reference twice using the “Automatic” tab as it will be treated as two separate references. The reference list in this section will be automatically generated and sorted''</span><span style="color:#0070C0">''.''</span><span style="color:#0070C0">)</span> <references />
    
<br />
 
<br />
    
==Notes==
 
==Notes==
−
<nowiki>*</nowiki>Primary authors will typically be those that initially create and complete the content of a page.  If a subsequent user modifies the content and feels the effort put forth is of high enough significance to warrant listing in the authorship section, please contact the CCGA coordinators (contact information provided on the homepage).  Additional global feedback or concerns are also welcome.
+
<nowiki>*</nowiki>Primary authors will typically be those that initially create and complete the content of a page.  If a subsequent user modifies the content and feels the effort put forth is of high enough significance to warrant listing in the authorship section, please contact the [[Leadership|''<u>Associate Editor</u>'']] or other CCGA representative.  When pages have a major update, the new author will be acknowledged at the beginning of the page, and those who contributed previously will be acknowledged below as a prior author.
 +
 
 +
Prior Author(s): 
 +
 
 +
       
 
<nowiki>*</nowiki>''Citation of this Page'': “Hepatosplenic T-cell lymphoma”. Compendium of Cancer Genome Aberrations (CCGA), Cancer Genomics Consortium (CGC), updated {{REVISIONMONTH}}/{{REVISIONDAY}}/{{REVISIONYEAR}}, <nowiki>https://ccga.io/index.php/HAEM5:Hepatosplenic_T-cell_lymphoma</nowiki>.
 
<nowiki>*</nowiki>''Citation of this Page'': “Hepatosplenic T-cell lymphoma”. Compendium of Cancer Genome Aberrations (CCGA), Cancer Genomics Consortium (CGC), updated {{REVISIONMONTH}}/{{REVISIONDAY}}/{{REVISIONYEAR}}, <nowiki>https://ccga.io/index.php/HAEM5:Hepatosplenic_T-cell_lymphoma</nowiki>.
 
[[Category:HAEM5]]
 
[[Category:HAEM5]]
 
[[Category:DISEASE]]
 
[[Category:DISEASE]]
 
[[Category:Diseases H]]
 
[[Category:Diseases H]]
Retrieved from "https://ccga.io/index.php/Special:MobileDiff/16082"